A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P174
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sharma, Padmanee
Grimm, Marc-Oliver
Galsky, Matthew D
Baron, Ari
Bracarda, Sergio
Siefker-Radtke, Arlene
Lambert, Alexandre
Azrilevich, Alex
Retz, Margitta
Article History
First Online: 4 November 2015